No Data
No Data
Kangwei Century (688426.SH): A total of 2.2774% of shares have been repurchased.
On February 5, Glonghui reported that Kangwei Century (688426.SH) announced that as of the close on January 27, 2025, the company has repurchased a total of 2,561,914 shares through the trading system of the Shanghai Exchange via centralized bidding, accounting for 2.2774% of the company's total share capital of 112,493,716 shares. The highest repurchase price was 25.68 yuan/share, the lowest price was 15.01 yuan/share, and the total amount paid was 47,650,240.73 yuan (excluding stamp duty, trading commission, and other transaction costs).
Kangwei Century: 2024 Annual Results Pre-loss Announcement
2024 Annual Results Advance Loss Announcement
Express News | Kangwei Century: It is expected that the annual Net income for 2024 will be a loss of between 0.142 billion yuan and 0.17 billion yuan.
Kangwei Century (688426.SH) products have obtained Class III medical instruments registration certificate.
Kangwei Century (688426.SH) announced that recently, the company's wholly-owned subsidiary Jiangsu Jianwei Diagnostic Technology Co., Ltd. (...)
Express News | Kangwei Century: The A/B influenza and respiratory syncytial virus nucleic acid detection kits have obtained a Class III medical instruments registration certificate.